For the Inventor, By the Inventor

Enter assignee name

Bengaluru, India

Advinus Therapeutics Private Limited

USPTO Granted Patents = 15

EPO Patents = 9

Trademarks = 1

Forward Citations = 82

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Dinesh Barawkar (7 out of 10 patents)

Debnath Bhuniya (6 out of 15 patents)

Kasim A Mookhtiar (6 out of 6 patents)

4. Yogesh Waman (6 out of 7 patents)

5. Sujay Basu (6 out of 12 patents)

6. Venkata Poornapragnacharyulu Palle (6 out of 104 patents)

7. Summon Koul (5 out of 6 patents)

8. Vidya Ramdas (5 out of 10 patents)

9. Meena Patel (4 out of 10 patents)

10. Anil Panmand (4 out of 7 patents)

11. Santosh Kurhade (3 out of 3 patents)

12. Robert Zahler (2 out of 74 patents)

13. Anil M Deshpande (2 out of 3 patents)

14. Umesh Singh (2 out of 11 patents)

15. Partha Mukhopadhyay (2 out of 2 patents)

15 patents: Sort by Forward Citations

1. 10435402 - Bicyclic compounds, compositions and medicinal applications thereof (2019-10-08),

2. 9682953 - Amide compounds, compositions and applications thereof (2017-06-20),

3. 9593115 - Substituted fused tricyclic compounds, compositions, and medicinal applications thereof (2017-03-14),

4. 9550793 - Spirocyclic compounds, compositions and medicinal applications thereof (2017-01-24),

5. 9340506 - Acetamide derivatives as glucokinase activators, their process and medicinal applications (2016-05-17),

6. 9284316 - Substituted fused pyrimidine compounds (2016-03-15),

7. 9233983 - Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof (2016-01-12),

8. 9193698 - Process for preparing fluoxastrobin (2015-11-24),

9. 9115133 - Substituted fused tricyclic compounds, compositions and medicinal applications thereof (2015-08-25),

10. 9006177 - Fused tricyclic compounds as adenosine receptor antagonist (2015-04-14),

11. 8940900 - 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application (2015-01-27),

12. 8940751 - Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications (2015-01-27),

13. 8859566 - Substituted fused pyrimidine compounds (2014-10-14),

14. 8796290 - Substituted fused pyrimidine compounds, its preparation and uses thereof (2014-08-05),

15. 8501955 - Acetamide derivatives as glucokinase activators, their process and medicinal application (2013-08-06),

Advinus Therapeutics Private Limited is a pharmaceutical research company that specializes in drug discovery and development. Established in 2005, the company is headquartered in Pune, India. Advinus Therapeutics has a diverse portfolio of research programs and expertise in areas such as oncology, metabolic diseases, inflammation, and neuroscience. The company utilizes advanced technology and innovative approaches to develop novel therapies and bring them to market. Advinus Therapeutics strives to make a significant impact on global healthcare through its research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#20 in Bengaluru

#122 in India

#38,728 in the World

Bengaluru, India

Advinus Therapeutics Private Limited

Forward Citations = 82

54 inventors:

Dinesh Barawkar (7 out of 10 patents)

Debnath Bhuniya (6 out of 15 patents)

Kasim A Mookhtiar (6 out of 6 patents)

4. Yogesh Waman (6 out of 7 patents)

5. Sujay Basu (6 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…